Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Cost-Effectiveness of PDL1 Based Test-And-Treat Strategy with Pembrolizumab as the 1st Line Treatment for NSCLC in Hong Kong Proceeding/Conference:Journal of Thoracic Oncology | 2017 | |||
2019 | 26 | |||
Pembrolizumab in patients with advanced/metastatic acral lentiginous melanoma Proceeding/Conference:Annals of Oncology | 2017 | 65 |